Free Trial
OTCMKTS:ANPCY

ANGLE (ANPCY) Stock Price, News & Analysis

C$2.44
0.00 (0.00%)
(As of 07/26/2024 ET)
Today's Range
C$2.44
C$2.44
50-Day Range
C$2.12
C$2.70
52-Week Range
C$1.13
C$4.00
Volume
N/A
Average Volume
1,572 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ANPCY stock logo

About ANGLE Stock (OTCMKTS:ANPCY)

ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products in Europe, North America, and the United Kingdom. The company develops and commercializes Parsortix cell separation system, which captures and harvests circulating tumor cells in metastatic breast cancer patient blood; and HyCEAD. ANGLE plc has a partnership agreement with Bio View Ltd to develop a liquid biopsy circulating tumor cell HER2 assay for breast cancer. The company was founded in 1994 and is based in Guildford, the United Kingdom.

ANPCY Stock Price History

ANPCY Stock News Headlines

ANGLE unveils groundbreaking cancer diagnostic tool
Get out of cash before the Fed's next meeting
"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all $20,000 of his wife's 401k into shares of just ONE stock. Everyone on Wall Street said he was crazy. But a year later, that $20,000 in his wife's account was worth $120,000. Today, he says: "If you thought the dot-com mania was intense, what's about to happen in the coming weeks could be even crazier and could open up a new window of opportunity for 500%-plus gains."
Get out of cash before the Fed's next meeting
"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all $20,000 of his wife's 401k into shares of just ONE stock. Everyone on Wall Street said he was crazy. But a year later, that $20,000 in his wife's account was worth $120,000. Today, he says: "If you thought the dot-com mania was intense, what's about to happen in the coming weeks could be even crazier and could open up a new window of opportunity for 500%-plus gains."
Angle: Big Takeaways
See More Headlines
Receive ANPCY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ANGLE and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Diagnostics & Research
Sub-Industry
N/A
Current Symbol
OTCMKTS:ANPCY
Fax
N/A
Employees
173
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
10 Best Stocks to Own in 2024 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Mr. Andrew David William Newland ACA (Age 63)
    Meng, Founder, CEO & Executive Director
    Comp: $336.31k
  • Mr. Ian Francis Griffiths ACA (Age 60)
    BA, CFO, Finance Director, Company Secretary & Executive Director
    Comp: $208.92k
  • Mr. Martin Cooke (Age 55)
    Director of Operations & Regulatory Affairs
  • Dr. Karen Miller Ph.D.
    Chief Scientific Officer
  • Mr. Andrew John Holder (Age 56)
    Head of Investor Relations
  • Ms. Anne-Sophie Pailhes-Jimenez
    Head of R&D and Senior Director
  • Mr. Brett Swansiger
    Chief Commercial Officer
  • Mr. Nick Claxton
    Senior Vice President of Commercial Operations

ANPCY Stock Analysis - Frequently Asked Questions

How have ANPCY shares performed this year?

ANGLE's stock was trading at C$1.52 at the beginning of the year. Since then, ANPCY stock has increased by 60.5% and is now trading at C$2.44.
View the best growth stocks for 2024 here
.

How do I buy shares of ANGLE?

Shares of ANPCY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:ANPCY) was last updated on 7/27/2024 by MarketBeat.com Staff

From Our Partners